Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with
glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) …

The objective of this meta-analysis was to evaluate the effect of prostaglandin analogues
(PGA) on central corneal thickness (CCT) in patients with glaucoma. Key electronic …

Purpose To evaluate the effects of latanoprost, bimatoprost, and travoprost eye drops and
their preservatives on each corneal layer thickness in patients with primary open-angle …

Purpose To evaluate the effects of each subgroup of prostaglandin analogues (PGAs) on
central corneal thickness (CCT) in patients with normal tension glaucoma (NTG). Methods …

Purpose: The purpose of this study is to determine the effects of naïve use of prostaglandin
analogues (PGA) on IOP and anterior chamber volume (ACV), as well as investigate how …

Glaucoma is the second leading cause of blindness globally. Reducing intraocular pressure
(IOP) has been acknowledged to be the main therapy for glaucoma. Prostaglandin …

Aims To determine the influence of prostaglandin analogues (PGAs) on corneal
biomechanical properties in patients undergoing chronic treatment for primary open-angle …

Purpose To evaluate the effect of prostaglandin analogs (PGAs) on the biomechanical
properties (corneal hysteresis [CH], corneal resistance factor [CRF]) and central corneal …

Purpose: Recent studies have shown that prostaglandin analogues can decrease the
central corneal thickness (CCT), however, most of those studies followed the patient's CCT …

Purpose This paper aimed to evaluate the intraocular pressure (IOP)-lowering effects of
prostaglandin analogs (PGAs) in Japanese patients with normal-tension glaucoma (NTG) by …